Invenomic Capital Management LP Dentsply Sirona Inc. Transaction History
Invenomic Capital Management LP
- $1.99 Billion
- Q1 2025
A detailed history of Invenomic Capital Management LP transactions in Dentsply Sirona Inc. stock. As of the latest transaction made, Invenomic Capital Management LP holds 2,476,906 shares of XRAY stock, worth $40.9 Million. This represents 1.86% of its overall portfolio holdings.
Number of Shares
2,476,906
Previous 2,639,161
6.15%
Holding current value
$40.9 Million
Previous $50.1 Million
26.13%
% of portfolio
1.86%
Previous 2.44%
Shares
3 transactions
Others Institutions Holding XRAY
# of Institutions
402Shares Held
197MCall Options Held
709KPut Options Held
498K-
Vanguard Group Inc Valley Forge, PA20.7MShares$342 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.7MShares$309 Million0.01% of portfolio
-
First Eagle Investment Management, LLC14.4MShares$238 Million0.45% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD14MShares$230 Million0.03% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA12.1MShares$199 Million0.71% of portfolio
About DENTSPLY SIRONA Inc.
- Ticker XRAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 215,452,000
- Market Cap $3.55B
- Description
- DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental...